|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services, ITB study patient -Phase II Trial of Safety and Tolerability Study of TCD601 (Siplizumab) a Human Anti-CD2 Antibody Combined With Donor Bone Marrow Cell Infusion and Non-myeloab |
01/08/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Epic tips and tricks Extended Stay BMT Inpatients |
01/15/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Patient Selection Conference 01 22 25 |
01/22/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services,Patient Selection Conference Early mortality case review Extended Stay BMT Inpatients 01 29 25 |
01/29/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Patient Selection Conference recruitment. |
02/05/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Patient Selection Conference Extended Stay BMT Inpatients 02 12 25 |
02/12/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Journal club-Healthcare costs among patients with hematologic malignancies receiving allogenic transplants a US payer perspective TB screening for stem cell donors |
02/19/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Epic tips and tricks/ DLI Boost Therapy plan updates Patient Selection Conference Extended Stay BMT Inpatients 02 26 25 |
02/26/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Patient Selection Conference March 5 2025 |
03/05/2025 - 7:30am to 8:30am |
|
Bone Marrow Transplant Weekly Meeting 2025 Inpatient Outpatient Services Patient selection conference Extended inpatient stay 3 12 25 |
03/12/2025 - 7:30am to 8:30am |
Facebook
X
LinkedIn
Forward